Multikinase inhibitors

INCY 15 Pill - white oval, 15mm

Generic Name: ruxolitinib

Pill with imprint INCY 15 is White, Oval and has been identified as Jakafi 15 mg. It is supplied by Incyte Corporation.

Jakafi is used in the treatment of Myelofibrosis; Myeloproliferative Disorders; Polycythemia Vera; Graft-versus-host disease and belongs to the drug class multikinase inhibitors. Risk cannot be ruled out during pregnancy. Jakafi 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Jakafi (Ruxolitinib [ rux-oh-li-ti-nib ])-INCY 15-15 mg-White-Oval
Jakafi (Ruxolitinib [ rux-oh-li-ti-nib ])-INCY 15-15 mg-White-Oval

Jakafi
Generic Name: ruxolitinib [ rux-oh-li-ti-nib ]
Imprint: INCY 15
Strength: 15 mg
Color: White
Size: 15.00 mm
Shape: Oval
Availability: Prescription only
Drug Class: Multikinase inhibitors
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 50881-0015
Inactive Ingredients: Microcrystalline cellulose, Lactose monohydrate, Silicon dioxide, Povidone, Sodium starch glycolate type A potato, Magnesium stearate,
Latest News
Related Drugs